Our Experience

Experience matters when it comes to conducting a successful clinical trial. Dr. Lillestol, our principal investigator, created this clinic because of his personal and professional commitment to the improvement of treatment and medication available. His passion is the driving force behind our proven model of patient care. This has not only ensured our success as a trusted resource for patients, but has also made us a recognized and reputable partner for pharmaceutical sponsors.

With hundreds of completed clinical trials in our archives, Lillestol Research has the ability and capacity to quickly and efficiently manage your trial study from startup to closeout.

Benefits of Working with Lillestol Research

  • Central IRB site
  • Premier site status among many pharmaceutical sponsors
  • Recognized as high enroller
  • Patient attrition rate of less than 5% (lost to follow up and withdrawal)
  • Studies up and running within 2 weeks
  • CLIA waiver

No Red Tape. No Extra Committees. No Waiting Periods.

Lillestol Research is an ideal trial site because of our patient population and regional demographic. We have a stoic, reliable community that has produced excellent patient retention rates across all of our clinical trials. Even challenging outcomes trials requiring lengthy participation for our patients have seen excellent retention statistics.

When the success of your clinical trial is on the line, you can’t afford the risk of second-rate research team. That’s why Lillestol Research has become a trusted partner for these pharmaceutical sponsors and CROs:

  • Abbott
  • Actelion
  • Akcea
  • Alexion
  • Allakos, Inc
  • Amarin
  • Amgen
  • Amylin
  • Anthos Therapeutics
  • Ardea
  • Astellas
  • AstraZeneca
  • Avillion
  • Bausch & Lomb
  • Biohaven
  • Biota
  • BioSante
  • Boehringer-Ingelheim
  • Bristol Myers Squibb
  • CardioKine
  • Centrexion
  • Cerimon
  • Circassia
  • CombinatoRx
  • ContraVir
  • Covance
  • Daiichi-Sankyo
  • DP Clinical
  • Dr. Reddy's Laboratories Ltd
  • Duke CRI
  • Eisai
  • Endo Pharmaceuticals
  • Esperion
  • Exact Sciences
  • Foamix
  • Forest
  • Furiex
  • Galapagos
  • Gan & Lee
  • Genentech
  • GlaxoSmithKline
  • Guardant Health
  • Hanmi
  • Hisamitsu
  • ICON
  • i3 Research
  • IL Pharma
  • INC Research
  • InVentiv Health
  • Ironwood
  • Kowa Research Institute
  • LBR Regulatory
  • Lexicon
  • Lilly
  • MedImmune
  • Menarini
  • Merck
  • Metacrine
  • Moderna
  • Mylan
  • Myovant
  • New Amsterdam Pharma
  • Novartis
  • Novo Nordisk
  • NPS Allelix
  • NPS Pharmaceuticals
  • Ortho-McNeill
  • Otsuka
  • Palatin
  • Parexel
  • Pearl Therapeutics
  • Pfenex
  • Pfizer
  • PPD
  • PRA
  • Premier Research
  • Prosciento
  • Quintiles
  • Radius Health, Inc.
  • Roche
  • Salix
  • Samumed
  • Sanofi-Aventis
  • Schering-Plough
  • Sepacor
  • Smith Kline Beecham
  • SPRI Clinical Trials
  • Sunovion
  • Synergy
  • Taiwan Liposome Company, LTD
  • Takeda
  • Tasso
  • Teva
  • Theracos
  • TherapeuticsMD
  • Theravance
  • Tioga
  • Tonix
  • Transition Therapeutics
  • Trimel Biopharma SRL
  • Velicept
  • Viropharma
  • Wyeth
  • Zosano

See what we’ve been working on by visiting our current and completed trials pages.